Benitec Biopharma Announces the Completion of Redomiciliation to the United States
Benitec Biopharma Inc. (BNTC)
US:NASDAQ Investor Relations:
benitec.com/for-investors/investor-faqs
Company Research
Source: PR Newswire
HAYWARD, Calif., April 15, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) is pleased to announce that the previously announced transaction to redomicile from Australia to the United States has been fully implemented today. The redomiciliation was approved by Benitec shareholders at a Scheme Meeting held on March 26, 2020, and confirmed by the Supreme Court of Queensland on March 30, 2020.The shares of Benitec Biopharma, Inc. common stock issued today in connection with the redomiciliation will trade on The Nasdaq Capital Market LLC ("Nasdaq") under the symbol "BNTC", and Benitec Biopharma Inc. will continue to be subject to the reporting requirements of the U.S. Securities and Exchange Commission ("SEC") and applicable corporate governance rules of Nasdaq. Further details regarding the implementation of the redomiciliation can be found in filings made today with the SEC.About Benitec Biopharma, Inc.Benitec Biopharma, Inc. ("Benitec" or the "Company") is a development-stage
Show less
Read more
Impact Snapshot
Event Time:
BNTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTC alerts
High impacting Benitec Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
BNTC
News
- Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]Yahoo! Finance
- Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational UpdateGlobeNewswire
- Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare ConferenceGlobeNewswire
- Benitec Biopharma Inc. (NASDAQ: BNTC) had its "overweight" rating re-affirmed by analysts at Piper Sandler.MarketBeat
- Benitec Biopharma: OPMD Program Continues To Advance With Catalysts [Seeking Alpha]Seeking Alpha
BNTC
Sec Filings
- 11/21/24 - Form 4
- 11/18/24 - Form SC
- 11/14/24 - Form SCHEDULE
- BNTC's page on the SEC website